IGF1R and cancer: Insulin resistance and hyperinsulinemia in diabetes further drive cancer progression by activating IR and IGF‐1R pathways, particularly the PI3K/AKT/mTOR cascade, which enhances cell proliferation, survival, and angiogenesis (Figure 1).